![Trial demonstrates efficacy of inhaled budesonide to treat COVID-19 in the community - The Pharmaceutical Journal Trial demonstrates efficacy of inhaled budesonide to treat COVID-19 in the community - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/08/Pulmicort-inhaler.jpg)
Trial demonstrates efficacy of inhaled budesonide to treat COVID-19 in the community - The Pharmaceutical Journal
![Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/767a0abb-324b-4829-9e5e-faa91e2e9f18/gr1_lrg.jpg)
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet
Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests — Clinical BioManufacturing Facility
![Second study confirms benefits of budesonide in early stages of COVID-19 - NIHR Oxford Biomedical Research Centre Second study confirms benefits of budesonide in early stages of COVID-19 - NIHR Oxford Biomedical Research Centre](https://oxfordbrc.nihr.ac.uk/wp-content/uploads/2021/08/Budesonide-pic-11.2.2021-06.png)
Second study confirms benefits of budesonide in early stages of COVID-19 - NIHR Oxford Biomedical Research Centre
![Inhaled asthma drug shortens Covid recovery and could be 'significant for world,' study finds | The Independent Inhaled asthma drug shortens Covid recovery and could be 'significant for world,' study finds | The Independent](https://static.independent.co.uk/2021/04/12/19/iStock-1286705844.jpg?quality=75&width=982&height=726&auto=webp)